1. Wang H, Liu J, Liu K, Liu Y, Wen J, Wang Z*, Wen S*.Association of ECE1 gene polymorphisms and essential hypertension risk in the Northern Han Chinese: A case-control study.Mol Genet Genomic Med.2020.8(4).e1188..SCI |
2. 李笑,罗兴才,王佐广*,吴琼,辛毅,刘洁琳,刘雅,魏永祥*.转录因子c-Jun对人血管平滑肌细胞中线粒体融合基因2表达调控作用的实验研究.心肺血管病杂志.2019.38(5).538-543.核心期刊 |
3. Jin F, Li X, Wang Z*, Liu Y, Liu J, Sun D, Jin Y, Wang S, Wen S, Wei Y*.Association of mitofusin 2 methylation and essential hypertension: a case-control study in a Chinese population.Hypertens Res.2018.41(8).605-613.SCI |
4. Xiao L, Yongxiang W*, Zuoguang W* .microRNA-21 and hypertension.Hypertension research.2018.41(9).649-661.SCI |
5. 王佐广,靳飞,李笑,刘雅,刘洁琳,孙东东,李闯,文杰,温绍君,魏永祥*.线粒体融合基因2新变异位点A-35G与原发性高血压的相关性研究.心肺血管病杂志.2017.36(3).165-169.核心期刊 |
6. Wang Z, Niu Q#, Peng X, Li M, Liu K, Liu Y, Liu J, Jin F, Li X, Wei Y*.Candesartan cilexetil attenuated cardiac remodeling by improving expression and function of mitofusin 2 in SHR.Int J Cardiol.2016.214.348-357.SCI |
7. Wang Z, Peng X, Li M, Jin F, Zhang B, Wang H, Wei Y*.Is human cytomegalovirus infection associated with essential hypertension? A meta-analysis of 11,878 participants.J Med Virol.2016.88(5).852-858.SCI |
8. Zuoguang Wang*, Xiaoyun Peng,Yongxiang Wei.A New Theoretical Medical Model: The Four Dimensional Model.British Journal of Medicine & Medical Research.2016.11(3).1-6. |
9. Wang Z, Niu Q#, Peng X, Li M, Liu Y, Liu J, Wen S, Wei Y*.Mitofusin 2 ameliorates aortic remodeling by suppressing ras/raf/ERK pathway and regulating mitochondrialfunction in vascular smooth muscle cells.Int J Cardiol.2015.178.165-167.SCI |
10. 王佐广,彭晓云,李梅,张蓓,王丽娟,刘洁琳,刘雅,魏永祥,温绍君*.缬沙坦治疗原发性高血压患者血浆蛋白质组研究.中华老年心脑血管病杂志.2014.16(4).343-348.核心期刊 |
11. Wang Z, Liu Y, Liu J, Niu Q, Wen J, Wen S#, Wu Z.A novel 5'-uncoding region -1248 A>G variation of mitofusin-2 gene is associated with hypertension in Chinese.Yonsei Med J.2013.54(3).603-608.SCI |
12. Zuoguang Wang,Xiaoyun Peng,Yongxiang Wei*,Shaojun Wen.Neglect of Several Important Indexes During the Study of Human.J Clin Hypertens (Greenwich).2013.15(11).769-771.SCI |
13. 王佐广,牛秋丽,刘雅,刘洁琳,顾伟,刘阔,楼煜清,文杰,吴兆苏,温绍君*.线粒体融合基因2启动子的生物信息学研究.中国动脉硬化杂志.2013.21(2).97-104.核心期刊 |
14. Wang ZG; Liu Y; Liu JL; Liu K; Wen J; Wen SJ*; Wu ZS.HSG/Mfn2 gene polymorphism and essential hypertension: a case-control association study in Chinese.J Atheroscler Thromb.2011.18(1).24-31.SCI |
15. Zuoguang Wang, Ya Liu, Jieling Liu, Kuo Liu, Yuqin Lou, Jie Wen, Qiuli Niu, Shaojun Wen*, Zhaosu Wu .E-selectin gene polymorphisms are associated with essential hypertension: a case-control pilot study in Chinese.BMC Medical Genetics.2011.27(11).127-133.SCI |
16. 王佐广,牛秋丽,刘雅,刘洁琳,顾伟,刘阔,楼煜清,文杰,吴兆苏,温绍君*..中国人ACEI/D基因多态性与高血压患者ACEI降压效果的meta分析.中国现代医学杂志.2010.20(23).3566-3570.核心期刊 |
17. 王佐广,彭晓云,温绍君*,王绿娅,刘雅,刘洁琳,文杰.乐脂平加心脑舒通胶囊治疗混合型高脂血症疗效观察.中西医结合心脑血管病杂志.2010.8(12).1424-1426.核心期刊 |
18. Wang Z,Peng X,Tao Y,Liu Y,Liu J,Chen X,Wen S*,Wu Z.Is Prehypertension Really from Normotension and Hypertension? A Case-Control Pilot Proteomic Study in Chinese.Clinical and Experimental Hypertension.2009.31(4).316-329.SCI |